CLINICAL_TRIALS
trial_result
· 2025-08-22
Clinical Trial Update: Ropeginterferon for Treatment Free Remission [Phase 4]
Summary
Phase 4 trial evaluating Ropeginterferon alfa-2b for treatment-free remission in chronic myeloid leukemia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dong-Wook Kim | Conditions: CML (Chronic Myelogenous Leukemia) | Phase 4 | Status: COMPLETED